glp 1 drugs and breast cancer Researchers from Penn Medicine found that women taking GLP-1 are less likely to be diagnosed with cancer., @drcelinegounder breaks down the study’s findings whether the drugs caused GLP-1s in Oncology: Nursing Insights
Description
CDC [Internet]

& Trujillo, J

A small minority report mood changes

Orforglipron has demonstrated substantial glucose-lowering efficacy across multiple Phase 2 and Phase 3 trials in type 2 diabetes
In addition, his institutions received research grants from Arrowhead Pharmaceuticals, Astrazeneca, Terns Pharmaceuticals, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, Galectin Therapeutics, Galmed Pharmaceuticals, Gilead, Intercept, Hanmi, Intercept, Inventiva, Ionis, Janssen, Madrigal Pharmaceuticals, Merck, NGM Biopharmaceuticals, Novo Nordisk, Merck, Pfizer, Sonic Incytes
